期刊文献+
共找到11篇文章
< 1 >
每页显示 20 50 100
iNOS抑制剂aminoguanidine对脑缺血再灌注时相半暗带氨基酸水平的影响
1
作者 张绍东 连睿 《中国药理学会通讯》 2002年第1期46-46,共1页
关键词 INOS抑制剂 脑缺血再灌注 氨基酸 半暗带 动物实验 aminoguanidine
下载PDF
Effect of aminoguanidine on caspase-3 expression in rat retina after ischemia-reperfusion injury 被引量:2
2
作者 Yang Yang, Dian-Wen Gao 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2011年第3期259-261,共3页
AIM: To investigate the effect of aminoguanidine(AG) on the expression of caspase-3 in rat retina after ischemiareperfusion injury.METHODS: The rats were anesthetized with 30mg/kg sodium pentobarbital introperitoneal(... AIM: To investigate the effect of aminoguanidine(AG) on the expression of caspase-3 in rat retina after ischemiareperfusion injury.METHODS: The rats were anesthetized with 30mg/kg sodium pentobarbital introperitoneal(ip) injections.After topical application of 10g/L dicaine,the anterior chamber was punctured with a 5-gauge needle connected to a bottle containing normal saline.Intraocular pressure was raised to 100 mmHg by elevating the saline container.The infusion needle was removed from the anterior chamber 60 minutes later.Reperfusion of the retinal vasculature was confirmed by fundus examination.AG 100mg/kg was ip injected in drug group.The rats were then euthanatized at 6,24,and 72 hours after reperfusion,and their eyes were enucleated for immunohistochemistry.RESULTS: No specific staining was detected by using the caspase-3 antibody in the retina of control group.In ischemia group,the protein of caspase-3 was over-expressed at 6 hours and relieved at 24 hours and 72 hours,while with drug treatment,the expression of protein of caspase-3 was decreased at each time point.CONCLUSION: AG provides retinal protection against ischemia-reperfusion injury in rat retina,probably through an inducible NOS-dependent mechanism. 展开更多
关键词 aminoguanidine ISCHEMIA-REPERFUSION CASPASE-3
原文传递
Effects of aminoguanidine on retinal apoptosis in mice with oxygen-induced retinopathy 被引量:1
3
作者 An-Jie Du Bing Ren +3 位作者 Xiao-Wei Gao Lei Yang Yan Fu Xu-Dong Zhao 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2013年第4期436-441,共6页
AIM:To explore the protective effects of amino-guanidine(AG) on retinal apoptosis in mice with oxygeninduced retinopathy(OIR).·METHODS:A total of 80 C57BL/6J mice,aged 7 days,were randomly divided into four group... AIM:To explore the protective effects of amino-guanidine(AG) on retinal apoptosis in mice with oxygeninduced retinopathy(OIR).·METHODS:A total of 80 C57BL/6J mice,aged 7 days,were randomly divided into four groups:normal,high oxygen,high oxygen saline and high oxygen treated with AG.In the normal group,mice were housed in normoxic conditions from postnatal day P7 to P17.Mice in the other 3 groups were placed under hyperoxic conditions(75 ±2% O2) in an oxygen-regulated chamber for 5 days and subsequently placed in normoxic conditions for 5days.Mice in the AG group were treated once daily,from P12 to P17,with AG hemisulfate(100mg/kg body weight,intraperitoneally) dissolved in physiological saline.An equivalent amount of 0.9% physiological saline was administered,as above,to mice in the high oxygen saline group.Ten mice were randomly selected from each group on P14 and on P17,euthanized and the retinas examined.Apoptotic cells in the retina were detected using the terminal-deoxynucleoitidyl transferase mediated nick end labeling(TUNEL) method.The expression of nitric oxide synthase(iNOS) in the retina was detected by immunohistochemistry and changes in rod cells were observed using electron microscopy.·RESULTS:TUNEL-positive cells and iNOS immunoreactive neurons were present in the inner nuclear and ganglion cell retinal layers of mice in the high oxygen group.The number of TUNEL-positive cells was significantly greater in the high oxygen group compared with the normal group(t =-20.81,P14d<0.05;t =-15.05,P17d<0.05).However,the number of TUNEL-positive cells in the AG treatment group was significantly lower(t =-13.21,P14d<0.05;t =-6.61,P17d<0.05) compared with thehigh oxygen group.The expression of iNOS was significantly higher in the high oxygen group compared with the normal group(t =-21.95,P14d<0.05;t =-17.30,P17d<0.05).However,the expression of iNOS in the AG treatment group was significantly lower(t =-12.17,P14d<0.05;t =-10.30,P17d<0.05) compared with the high oxygen group.The outer segments of the rods were disorganized and short in the high oxygen group.Rod morphology appeared to be slightly improved in the AG group.·CONCLUSION:AG may protect retinal neurons in OIR by inhibiting apoptosis.The mechanism may be related to iNOS. 展开更多
关键词 aminoguanidine RETINOPATHY of PREMATURITY APOPTOSIS inhibitor of NITRIC oxide SYNTHASE
原文传递
Glycation Induced Physicochemical Changes in Low-Density Lipoprotein and Its Role in Promoting Cholesterol Accumulation in Macrophages along with Antiglycation Effect of Aminoguanidine
4
作者 D. S. Jairajpuri S. Fatima Z. S. Jairajpuri 《Advances in Biological Chemistry》 2015年第5期203-214,共12页
The present study aimed at investigating physicochemical changes in modified LDL by sugars specifically fructose due to recent reports on its involvement in cardiovascular diseases and also glucose and their role in s... The present study aimed at investigating physicochemical changes in modified LDL by sugars specifically fructose due to recent reports on its involvement in cardiovascular diseases and also glucose and their role in subsequent in vitro accumulation of cholesterol in macrophages. Antiglycation action of aminoguanidine was also investigated. LDL isolated from human blood was incubated with fructose or glucose and aminoguanidine where indicated. The physicochemical changes in modified LDL were detected by electrophoretic, spectroscopic and chemical analysis. Accumulation of cholesterol and its inhibiton in human monocyte-derived macrophages incubated with modified LDL was determined by HPLC. Results showed increased relative electrophoretic mobility, hyperchromicity at 280 nm, development of AGE fluorescence, decrease in free amino groups and increased carbonyl content in glycated LDL as compared to native LDL. Also total cholesterol accumulated in macrophages was more for glycated LDL as compared to native LDL. The magnitude of changes was more prominent in case of fructose as compared to glucose. Aminoguanidine showed remarkable restriction of glycation-induced alterations in LDL and also in accumulation of cholesterol in macrophages. The study thus proclaims that LDL-AGEs formed by fructose may contribute to accelerated initiation of diabetes induced atherosclerosis via foam cells generation and aminoguanidine may have therapeutic potential against it. 展开更多
关键词 Glycation LDL-AGEs D-FRUCTOSE aminoguanidine Diabetes-Induced Atherosclerosis
下载PDF
Electrochemical Evaluation of Aminoguanidine Hydrazone Derivative with Potential Anticancer Activity:Studies of Glassy Carbon/CNT and Gold Electrodes Both Modified with PAMAM
5
作者 Marilya Palmeira Galdino da Silva Ygor Mendes de Oliveira +5 位作者 Anna Caroline Lima Candido Joao Xavier de Araujo-Junior Erica Erlanny da Silva Rodrigues Kadja Luana Chagas Monteiro Thiago Mendonca de Aquino Fabiane Caxico de Abreu 《Journal of Biomaterials and Nanobiotechnology》 2020年第1期33-48,共16页
Aminoguanidine hydrazones (AGHs) are a class of compounds that have interesting pharmacological activities. They are derived from the same chemical group as aminoguanidine, so it has mixed properties (receptor and don... Aminoguanidine hydrazones (AGHs) are a class of compounds that have interesting pharmacological activities. They are derived from the same chemical group as aminoguanidine, so it has mixed properties (receptor and donor) in the formation of hydrogen bonds. Its anticancer agent properties were recently highlighted, but the molecules of this class have solubility in aqueous solutions that can be considered low. The identification of this class, by a simple, sensitive and low-cost technique, such as electrochemistry, which also allows the evaluation of its solubilization process through agents such as PAMAM dendrimer is the main objective of the work described here. The electrochemical response of the LQM10 (AGH derivative) was evaluated, as well as its behavior in different electrochemical sensors. Electrochemical experiments were performed in buffered (phosphate at pH 7.02 and acetate at 4.5). LQM10 has a reversible oxidation peak with a potential of +0.22 V. It was efficiently detected in different electrodes tested (glass carbon/CNT, glass carbon/CNT/PAMAM), which proves the viability of the electrodes for various analyses and has the determination of the apparent constant association, indicating its interaction with the analysis that is higher in the presence of the PAMAM encapsulating agent. This was corroborated by the results for the modified gold electrode with MUA and PAMAM. The sum of the results shows the possibility of electrochemically evaluating the Aminoguanidine hydrazone derivative, the viability of electrodes employed and the greater solubilization of LQM10 in the presence of the PAMAM dendrimer. 展开更多
关键词 Drug Delivery aminoguanidine Hydrazone Modified Electrode PAMAM
下载PDF
一氧化氮在梗阻性黄疸大鼠肝、肾、肠组织中含量变化及意义 被引量:5
6
作者 蒋筱强 罗志强 +1 位作者 杨成义 黄明文 《消化外科》 CSCD 2002年第3期190-192,共3页
目的 了解一氧化氮(NO)在梗阻性黄疸大鼠肝、肾、肠组织中含量变化及意义。方法 大鼠胆总管结扎后,分别于第一周内和第三周内应用Aminoguanidine(AG)抑制NO合成,同时应用生理盐水(NS)作对照,检测不同时段抑制NO合成后大鼠肝、肾... 目的 了解一氧化氮(NO)在梗阻性黄疸大鼠肝、肾、肠组织中含量变化及意义。方法 大鼠胆总管结扎后,分别于第一周内和第三周内应用Aminoguanidine(AG)抑制NO合成,同时应用生理盐水(NS)作对照,检测不同时段抑制NO合成后大鼠肝、肾、肠组织中NO和丙二醛(MDA)含量、肌酐清除率(Ccr)血清总胆红素(T-BIL)和丙氨酸氨基转移酶(ALT)含量及肠系膜淋巴结细菌移位(BT)率的变化。结果 胆总管结扎后,大鼠肝、肾、肠组织中NO含量明显升高,在胆总管结扎第一周抑制NO合成后,肝、肾、肠组织中NO含量明显下降,MDA含量明显升高,血ALT明显升高、Ccr明显下降、肠系膜淋巴结BT率明显升高;而在胆总管结扎第三周抑制NO合成后,肝、肾、肠组织中NO和MDA含量明显下降,血ALT明显下降、Ccr明显升高。肠系膜淋巴结BT率明显下降。结论NO在胆道梗阻引起的肝、肾、肠粘膜屏障功能障碍的发生机制中具有重要作用,既有保护作用,又有损害作用。梗阻早期表现为对组织的保护作用,后期表现为对组织的损害作用。 展开更多
关键词 一氧化氮 梗阻性黄疸 大鼠 含量变化 aminoguanidine
下载PDF
SIRT2 regulates microtubule stabalization in diabetic cardiomyopath'.
7
《中国药理学通报》 CAS CSCD 北大核心 2015年第B11期189-190,共2页
Aim Stable microtubules (MTs) is involved the mechanism of diabetic cardiomyopathy (DCM), which is induced by acetylation of α-tubulin. The present study investigated whether SIRT2, a deacetylase, regulates MT st... Aim Stable microtubules (MTs) is involved the mechanism of diabetic cardiomyopathy (DCM), which is induced by acetylation of α-tubulin. The present study investigated whether SIRT2, a deacetylase, regulates MT stability through α-tubulin deacetylation in DCM and whether the receptor of advanced glycation end products (AGEs) signaling pathway is involved in this effect. Methods Type 1 diabetic mellitus (T1DM) rats model was established by a single intraperitoneal injection of streptozotocin (STZ, 65 mg · kg^-1) , and neonatal rat cardio- myocytes were also cultured. Heart function was detected by Doppler. MT stability was elevated by β-tubulin ex- pression density. The protein expression of SIRT2, acetylated α-tubulin and AGEs receptor were detected by immu- nohistochemistry or Western blots. The interaction of SIRT2 and acetylated α-tubulin was detected by Co-immuno- precipitation. Results In an animal model of T1DM, Western blot and immunohistochemistry revealed downregu- lation of SIRT2 but upregulation of the acetylated α-tubulin protein. These effects were reduced by treatment of aminoguanidine, an inhibitor of AGEs production. HDAC6 expression did not regulated in heart. In primary cul- tures of neonatal rat cardiomyocytes, the AGEs treatment impaired the SIRT2/acetylated α-tubulin signaling path- way, and SIRT2-overexpression reversed the function of AGEs on cardiomyocytes. In addition, gene silencing of AGEs receptor alleviated the impairment effect of AGEs on cardiomyocytes. Conclusion In conclusion, these data demonstrate that AGEs/AGEs receptor promote MT stabilization via the suppression of the SIRT2/acetylated α-tu- bulin signaling pathway in DCM development. 展开更多
关键词 SIRT2 acetylated Α-TUBULIN diabetic CARDIOMYOPATHY MICROTUBULE stabilization ADVANCED glycationend PRODUCTS receptor for ADVANCED glycation end PRODUCTS aminoguanidine
下载PDF
Synthesis, Thermal Behaviour, XRD, and Luminescent Properties of Lighter Lanthanidethiodipropionate Hydrates Containing Aminogunidine as Neutral Ligand
8
作者 S. Packiaraj S. Govindarajan 《Open Journal of Inorganic Chemistry》 2014年第3期41-49,共9页
Aminoguanidine lanthanide thiodipropionate hydrates of composition [Ln(Agun)2(tdp)3&#183nH2O], Agun = Aminoguanidine, tdp = thiodipropionic acid, where Ln = La, Pr, Nd and Sm if n = 2, have been prepared and chara... Aminoguanidine lanthanide thiodipropionate hydrates of composition [Ln(Agun)2(tdp)3&#183nH2O], Agun = Aminoguanidine, tdp = thiodipropionic acid, where Ln = La, Pr, Nd and Sm if n = 2, have been prepared and characterized by physic-chemical techniques. 展开更多
关键词 aminoguanidine 3 3-Thiodipropionic Acid Rare Earth Metals Spectral and Thermal Studies
下载PDF
Nitridergic Modulation of the Antinociceptive Activity of Rosuvastatin in Mice
9
作者 Viviana Noriega Fernando Sierralta +2 位作者 Juan Carlos Prieto Pilar Zanetta Hugo F. Miranda 《Pharmacology & Pharmacy》 2014年第1期61-68,共8页
Statins, 3-hydroxy-3 methylglutaryl coenzyme A (HMG-CoA) reductase enzyme inhibitors, are lipid-lowering drugs, often used in the treatment of cardiovascular diseases (hyperlipidemia, atherosclerosis). It has been sho... Statins, 3-hydroxy-3 methylglutaryl coenzyme A (HMG-CoA) reductase enzyme inhibitors, are lipid-lowering drugs, often used in the treatment of cardiovascular diseases (hyperlipidemia, atherosclerosis). It has been shown that statins have antiinflammatory effects independent of their lipid-lowering effects and these anti-inflammatory effects inhibit the inflammation and pain process. This study evaluated the antinociceptive and anti-inflammatory effects of rosuvastatin using the acetic acid writhing, the formalin hind paw, the orofacial formalin and the hot plate tests. The following experimental group were used: control, acute (1 day) and chronic (3 days) after oral gavage with rosuvastatin (3, 10, 30, 100 and 300 mg/kg). Rosuvastatin produced a dose-dependent antinociception, with different potency, in all the tests. Additionally, nitric oxide synthase inhibitors (Abbreviationsand aminoguanidine) were used to assess the nitric oxide participation on this induced rosuvastatin antinociception. The data demonstrated the antinociceptive and anti-inflammatory activity of rosuvastatin in algesiometer models of tonic or phasic pain. These activities seem to be induced by modulation of iNOS expression, a result that may be relevant in the pharmacological treatment of human pain where rosuvastatin and nitric oxide synthase inhibitors must be used. 展开更多
关键词 ANTINOCICEPTION ANTI-INFLAMMATION Algesiometer Assays ROSUVASTATIN L-NAME aminoguanidine
下载PDF
Effect of advanced glycosylation end products on activity of protein kinase C in human peripheral blood mononuclear cells 被引量:2
10
作者 童嘉毅 刘乃丰 《Chinese Medical Journal》 SCIE CAS CSCD 2000年第12期12-14,共3页
To investigate the effect of advanced glycosylation end products (AGEs) on the activity of protein kinase C (PKC) in human peripheral blood mononuclear cells (PBMC) and to observe whether aminoguanidine (AG) can influ... To investigate the effect of advanced glycosylation end products (AGEs) on the activity of protein kinase C (PKC) in human peripheral blood mononuclear cells (PBMC) and to observe whether aminoguanidine (AG) can influence the effect of AGEs Methods After PBMC were isolated from human peripheral blood and incubated with different concentrations of AGEs BSA for various periods, total PKC activity in PBMC was determined by measuring the incorporation of 32 P from [γ 32 P] ATP into a special substrate using Promega PKC assay kit Results AGEs BSA increased the total PKC activity in PBMC from 83 43±6 57?pmol/min/mg protein to 116 8±13 82?pmol/min/mg protein with a peak at 15?min AGEs BSA also increased the total PKC activity in a concentration dependent manner from 83 1±6 4?pmol/min/mg protein (control) to 119 1±13 3?pmol/min/mg protein (control vs AGEs BSA 400?mg/L, P <0 01) Furthermore, AGEs BSA induced an elevation of PKC activity in a glycosylating time related manner, from 80 9±8 2 (control) to 118 3±11 5?pmol/min/mg protein (glycosylation for 12 wk, P <0 01) The total PKC activity stimulated by AGEs BSA pretreated with AG (100, 200?mg/L) was markedly lower than that of AGEs BSA group not pretreated with AG ( P <0 05, P <0 01) Conclusions AGEs BSA increased the total PKC activity in PBMC in a concentration and incubation time dependent manner The ability of AGEs BSA to stimulate PKC activity was markedly decreased by pretreatment of AGEs BSA with 展开更多
关键词 ADVANCED GLYCOSYLATION END PRODUCTS · protein kinase C · MONONUCLEAR cells · aminoguanidine · signal transduction
原文传递
Advanced glycosylation end products, protein kinase C and renal alterations in diabetic rats
11
作者 戎健 邱鸿鑫 汪恕萍 《Chinese Medical Journal》 SCIE CAS CSCD 2000年第12期31-35,共5页
To study the relationship between advanced glycosylation end products (AGE) and protein kinase C (PKC), and their effects on renal alteration in diabetic rats Methods Insulin or aminoguanidine was administered to diab... To study the relationship between advanced glycosylation end products (AGE) and protein kinase C (PKC), and their effects on renal alteration in diabetic rats Methods Insulin or aminoguanidine was administered to diabetic rats Blood glucose, hemoglobin A 1C (HbA 1C ), glomerular tissue extracts AGE (GTE AGE), PKC, glomerular basement membrane thickness (GBMT) and urine protein/creatinine (Pr/Cr) ratio in diabetic rats were measured and analysed Results Levels of blood glucose, HbA 1C and AGE, PKC activity, the Pr/Cr ratio and GBMT were all significantly increased ( P values all less than 0 01) in diabetic rats Insulin could decrease the formation of HbA 1C and AGE, and improve PKC activity Aminoguanidine had no influence on PKC activity ( P >0 05) although it decreased the formation of AGE Both drugs could delay the increase of urine Pr/Cr ratio and GBMT ( P <0 05 or P <0 01) Conclusions Chronic hyperglycemia may lead to an increase of PKC activity HbA 1C and AGE may not directly contribute to alterations of PKC activity, but the increase of PKC activity could promote the action of AGE on GBM thickening It is important to inhibit the formation of AGE and reduce the PKC activity so as to prevent or delay the development of diabetic 展开更多
关键词 diabetic nephropathy nonenzymatic glycosylation protein kinase C INSULIN aminoguanidine advanced glycosylation end products glomerular basement membrane
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部